Who we are
We improve human health by applying the science of machine learning to develop algorithms to detect disease and monitor progression.
What we do
Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on liver disease detection and monitoring.
DID YOU KNOW?
1.Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcome. Hepatology 64(1): 73-84
2.Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 107: 811–826
Our Unique Liver Diagnostics Tests
The non-invasive solution for liver health evaluations
The Fibronostics Team
Meet The Team Behind LiverFASt™
Our Blogs
Top Innovating Doctors in Liver Health
The American Liver Foundation estimates that 30 million people in the US have one form of liver disease with up to 25 percent of the population affected by NAFLD.
Where’s the Beef? Here’s What You Need to Know When Grilling Your Food
Rare, medium rare, do you really know what you are doing? Did you know there are consequences to grilling your meats that can affect your health?
Binge Drinking Rates Continuing to Rise Among Young Adults
Did you know that binge drinking rates are continuing to rise in young adults once they’ve hit the legal drinking age?